Statistical Analysis All statistical analyses were conducted using the SPSS version 17.0 (SPSS, Chicago, Illinois, USA)
Do not attempt to adjust your dose or skip a dose without professional guidance, as this can destabilize your weight loss progress and appetite control
For decades, weight, metabolic health and infertility were approached in separate silos
Wegovy (semaglutide 2.4 mg) is a GLP-1 receptor agonist administered once weekly via subcutaneous injection for weight management in adults with obesity or overweight with comorbidities
For many people, these symptoms improve as the body gets used to the medication
For fitness brands focusing on holistic health, incorporating strength training with semaglutide use can be synergistic, ensuring clients lose fat while maintaining muscle integrity